Supreme Court corner — Q3 2013

In a split decision, the court found the proper judicial review of reverse settlement payments is a ‘rule of reason’ in light of the pro-competition nature of the Hatch-Waxman Act. Justice Breyer, writing for the majority, listed factors that may help to determine whether such a settlement is anticompetitive: size, scale in relation to future litigation costs, independence from other services for which it might represent payment, the industry, and the lack of other justification. The court’s adopted ‘rule of reason’ analysis finds a middle ground between the Second, Eleventh and Federal Circuits (deferential scrutiny), and the Third Circuit (presumptively invalid). This middle ground requires courts to conduct a more thorough anti-competition analysis. Such analysis need not be onerous, and the trial court is not required to reach the validity of the underlying patent(s) in every case.

This decision is likely a win for generic drug consumers, who may now benefit when some generics enter the marketplace sooner. The decision also provides some upside for drug manufacturers: the decision declined to find the settlements in question presumptively invalid, and added clarity for judicial review of such settlements…

If you are registered and logged in to the site, click on the link below to read the rest of the DLA Piper briefing. If not, please register or sign in with your details below.

Sign in or Register to continue reading this article

Sign in

Register

It's quick, easy and free!

It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.

Register now

Why register to The Lawyer

 

Industry insight

In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.

 

Market intelligence

Identify the major players and business opportunities within a particular region through our series of free, special reports.

 

Email newsletters

Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.

More relevant to you

To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.

Briefings from DLA Piper

View more briefings from DLA Piper

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

3 Noble Street
London
EC2V 7EE
UK
http://www.dlapiper.com

Turnover (£m): 1,566.29
No. of lawyers: 3,961 (UK 200)
Jurisdiction: global
No. of offices: more than 75
No. of qualified lawyers: 625 (International 50)

Jobs